Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

"Cerebral" diabetes - is it connected to diabetes mellitus? (CROSBI ID 494202)

Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | domaća recenzija

Šalković-Petrišić, Melita ; Lacković, Zdravko "Cerebral" diabetes - is it connected to diabetes mellitus? // Symposium on Movemnt Disorders: 4th Alpine Basal Ganglia Club & Selected Topics in Neuropharmacology, Final Programe & Book of Abstracts / Relja, Maja (ur.). Zagreb: Hrvatska udruga bolesnika s poremećajima pokreta, 2002. str. 26-x

Podaci o odgovornosti

Šalković-Petrišić, Melita ; Lacković, Zdravko

engleski

"Cerebral" diabetes - is it connected to diabetes mellitus?

Numerous literature data indicate that diabetes mellitus is accompanied by morphological, biochemical, electrophysiological and behavioral alterations of the central nervous system. At the biochemical level, probably the most explored ones are those of neurotransmitters, particularly monoamines. In animals with experimental diabetes, induced by betacytotoxic drugs alloxan and streptozotocin, we have found regionally specific changes of monoamine content, turnover rate, its transporters and (dopaminergic) receptors, respectively, in particular brain regions, pronounced in striatum and hypothalamus. The brain monoamine changes were not the consequence of non-specific toxic effects of betacytotoxics as similar ones were observed in brain regions of diabetic patients post mortem. Unexpectedly, we also found similar changes of monoamine content, turnover rate, its transporters and (dopaminergic) receptors, in animals that have been intracerebroventricularly (icv) treated with low, non-diabetogenic doses of alloxan and streptozotocin, and had a normal basal plasma glucose level. Regarding the glucose metabolism alterations reported to be found within the brain of streptozotocin icv treated, normoglycemic rats, and the existence of brain insulin system, the term &#8220 ; cerebral diabetes&#8221 ; has emerged in the literature, but its connection to diabetes mellitus is not clear yet. In line with these literature data, results of our experiments may suggest a possible explanation that could be related to the specific effects of betacytoxics upon the brain cells that potentially produce and/or release insulin. Furthermore, the connection between the &#8220 ; cerebral diabetes&#8221 ; and diabetes mellitus seems to be possible, as suggested by our preliminary results of altered glucose tolerance and insulin secretion following the oral glucose overload in betacytotoxic icv-treated rats that are normoglycemic at basal conditions.

diabetes mellitus; brain

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

26-x.

2002.

objavljeno

Podaci o matičnoj publikaciji

Symposium on Movemnt Disorders: 4th Alpine Basal Ganglia Club & Selected Topics in Neuropharmacology, Final Programe & Book of Abstracts

Relja, Maja

Zagreb: Hrvatska udruga bolesnika s poremećajima pokreta

Podaci o skupu

Symposium on Movemnt Disorders: 4th Alpine Basal Ganglia Club & Selected Topics in Neuropharmacology

pozvano predavanje

18.09.2002-21.09.2002

NP Plitvička jezera, Hrvatska

Povezanost rada

Kliničke medicinske znanosti